Evidence map›Paper›PMID 39745850›Full record

ArticleArchives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists2025

Rates and Predictors of Performance Validity Test Failure in Adults Treated for Post-COVID-19 Condition: a Brief Report.

Phoebe A Clark, Samantha Horn, Natalie Wang, Constantine G Lyketsos, Ann M Parker, Esther S Oh, Tracy D Vannorsdall

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Phoebe A ClarkDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Samantha HornDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Natalie WangJohns Hopkins Bloomberg School of Public Health, Baltimore, MD 21287, USA.
Constantine G LyketsosDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Ann M ParkerDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Esther S OhDepartment of Medicine, Department of Psychiatry and Behavioral Sciences, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Tracy D VannorsdallDepartment of Psychiatry and Behavioral Sciences, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0003-3103-1371

Funding

Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
Novel Blood Biomarker of Alzheimer's disease Using Oral Glucose ToleranceR01AG057725 · NIA · JOHNS HOPKINS UNIVERSITY · PI OH, ESTHER SEUNGHEE · 2017 to 2021
$2.4M
A Pilot, Feasibility Randomized Controlled Trial of a Behavioral Activation and Rehabilitation Intervention to Improve Psychological and Physical Impairments in Acute Respiratory Failure SurvivorsK23HL138206 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI PARKER, ANN MARIE · 2017 to 2020
$668k
Johns Hopkins Alzheimer's Disease Research Center P30AG066507NHLBI NIH HHS K23 HL138206NIA NIH HHS P30 AG066507NIA NIH HHS R01 AG057725NIH HHS K23HL138206NIH HHS R01AG057725
6 · The paper itself

Abstract

>

objectiveCognitive dysfunction is a common symptom of post-COVID-19 condition (PCC). Few studies have examined rates and predictors of cognitive performance validity test (PVT) failure in patients seeking treatment for PCC. >

methodsWe report the rates of PVT failure in 323 patients who received care in a long-COVID-19 clinic for any post-COVID-19 health concern and underwent routine telephone cognitive testing that included two embedded PVTs. Binary logistic regressions examined the demographic, illness, and psychological variables associated with PVT failure. >

resultsThe prevalence of single PVT failure ranged from 4.7% to 26.1% whereas failure on both PVTs occurred in just 6.3%. Illness characteristics, subjective cognitive dysfunction, and most demographic and psychological variables were unrelated to single PVT failure. Males and those with anxiety were more likely to fail both PVTs. >

conclusionFailure across multiple PVTs was not common and was unrelated to COVID-19 severity or cognitive complaints.

Indexed as

Cognitive DysfunctionCOVID-19Neuropsychological TestsAdultAgedFemaleHumansMaleMiddle AgedAssessmentInfectious diseases, non-HIVMalingering/symptom validity testing

Identifiers

PMID39745850
PMCPMC12290880

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.